Theriva Biologics, Inc. Treasury Stock, Common, Shares
Theriva Biologics, Inc. (TOVX) had Treasury Stock, Common, Shares of 28.81 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-08-11
- 2026-06-30: Treasury Stock, Common, Shares 28.81K shares.
- 2026-03-31: Treasury Stock, Common, Shares 28.81K shares.
- 2025-12-31: Treasury Stock, Common, Shares 28.81K shares; Treasury Stock, Common, Shares as first filed 28.81K shares.
- 2025-09-30: Treasury Stock, Common, Shares 28.81K shares.
| Period end | Treasury Stock, Common, Shares | Treasury Stock, Common, Shares as first filed |
|---|---|---|
| 2026-06-30 | 28.81K shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 28.81K shares 10-Q · filed 2026-05-05 | |
| 2025-12-31 | 28.81K shares 10-Q · filed 2026-08-11 | 28.81K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 28.81K shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 28.81K shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 28.81K shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 28.81K shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 28.81K shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 720.23K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 720.23K shares 10-Q · filed 2024-05-07 | |
| 2023-12-31 | 28.81K shares 10-K · filed 2025-03-06 | 720.23K shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 720.23K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 720.23K shares 10-Q · filed 2023-08-08 | |
| 2022-12-31 | 720.23K shares 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |